Role of PI3K/AKT pathway in cancer: the framework of malignant behavior

N Jiang, Q Dai, X Su, J Fu, X Feng, J Peng - Molecular biology reports, 2020 - Springer
Given that the PI3K/AKT pathway has manifested its compelling influence on multiple
cellular process, we further review the roles of hyperactivation of PI3K/AKT pathway in …

Targeting molecular mechanisms underlying treatment efficacy and resistance in osteosarcoma: a review of current and future strategies

I Lilienthal, N Herold - International journal of molecular sciences, 2020 - mdpi.com
Osteosarcoma is the most common primary malignant bone tumour in children and
adolescents. Due to micrometastatic spread, radical surgery alone rarely results in cure …

Pubchem bioassay: 2017 update

Y Wang, SH Bryant, T Cheng, J Wang… - Nucleic acids …, 2017 - academic.oup.com
PubChem's BioAssay database (https://pubchem. ncbi. nlm. nih. gov) has served as a public
repository for small-molecule and RNAi screening data since 2004 providing open access of …

Future directions in the treatment of osteosarcoma

MW Bishop, KA Janeway, R Gorlick - Current opinion in pediatrics, 2016 - journals.lww.com
Future directions in the treatment of osteosarcoma : Current Opinion in Pediatrics Future
directions in the treatment of osteosarcoma : Current Opinion in Pediatrics Log in or Register …

The kinome'at large'in cancer

EDG Fleuren, L Zhang, J Wu, RJ Daly - Nature Reviews Cancer, 2016 - nature.com
Over the past decade, rapid advances in genomics, proteomics and functional genomics
technologies that enable in-depth interrogation of cancer genomes and proteomes and high …

Novel insights and therapeutic interventions for pediatric osteosarcoma

L Kager, G Tamamyan, S Bielack - Future Oncology, 2016 - Taylor & Francis
High-grade osteosarcomas are the most common primary malignant tumors of bone. With
complete surgical resection and multi-agent chemotherapy up to 70% of patients with high …

PTEN in osteosarcoma: Recent advances and the therapeutic potential

C Zheng, F Tang, L Min, F Hornicek, Z Duan… - Biochimica et Biophysica …, 2020 - Elsevier
Osteosarcoma is the most common primary malignant bone tumor, predominantly occurring
in children and adolescents. Despite treated with surgery and neoadjuvant chemotherapy …

Carbon dot/WS2 heterojunctions for NIR-II enhanced photothermal therapy of osteosarcoma and bone regeneration

B Geng, H Qin, W Shen, P Li, F Fang, X Li… - Chemical Engineering …, 2020 - Elsevier
Osteosarcoma as an aggressive malignant neoplasm is commonly treated by surgical
resection, chemotherapy, and radiotherapy, but surgery induces bone defects and …

Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group

RD Roberts, MM Lizardo, DR Reed, P Hingorani… - Cancer, 2019 - Wiley Online Library
Patients who are diagnosed with osteosarcoma (OS) today receive the same therapy that
patients have received over the last 4 decades. Extensive efforts to identify more effective or …

W-Doped TiO2 Nanorods for Multimode Tumor Eradication in Osteosarcoma Models under Single Ultrasound Irradiation

B Geng, X Yang, P Li, W Shi, D Pan… - ACS Applied Materials & …, 2021 - ACS Publications
Sonosensitizers play crucial roles in the controlled production of reactive oxygen species
(ROS) under ultrasound (US) irradiation with high tissue-penetration depth for noninvasive …